|
|
||||||||
J Thorac Cardiovasc Surg 1994;107:1481-1488
© 1994 Mosby, Inc.
CARDIOPULMONARY BYPASS, |
Boston, Mass.
From the Department of Surgery, Cardiac Surgical Unit, Massachusetts General Hospital and Harvard Medical School, and the Naval Blood Research Laboratory, Boston University School of Medicine, Boston, Mass.
Received for publication April 30, 1993. Accepted for publication Aug. 30, 1993. Address for reprints: Gus J. Vlahakes, MD, Department of Surgery, Massachusetts General Hospital, Boston, MA 02114-2696.
Abstract
Postoperative pericardial adhesions complicate reoperative cardiac procedures. Topical application of solutions containing hyaluronic acid have been shown to reduce adhesions after abdominal and orthopedic surgery. The mechanism by which hyaluronic acid solutions prevent adhesion formation is unknown but may be due to a cytoprotective effect on mesothelial surfaces, which would limit intraoperative injury. In this study, we tested the efficacy and safety of hyaluronic acid coating solutions for the prevention of postoperative intrapericardial adhesion formation. Eighteen mongrel dogs underwent median sternotomy and pericardiotomy followed by a standardized 2-hour protocol of forced warm air desiccation and abrasion of the pericardial and epicardial surfaces. Group 1 (n = 6) served as untreated control animals. Group 2 (n = 6) received topical administration of 0.4% hyaluronic acid in phosphate-buffered saline solution at the time of pericardiotomy, at 20-minute intervals during the desiccation/abrasion protocol, and at pericardial closure. The total test dose was less than 1% of the circulating blood volume. Group 3 (n = 6) served as a vehicle control, receiving phosphate-buffered saline solution as a topical agent in a fashion identical to that used in group 2. At resternotomy 8 weeks after the initial operation, the intrapericardial adhesions were graded on a 0 to 4 severity scale at seven different areas covering the ventricular, atrial, and great vessel surfaces. In both the untreated control (group 1, mean score 3.2 ± 0.4) and vehicle control (group 3, mean score 3.3 ± 0.2) animals, dense adhesions were encountered. In contrast, animals treated with the hyaluronic acid solution (group 2, mean score 0.8 ± 0.3) characteristically had no adhesions or filmy, transparent adhesions graded significantly less severe than either the untreated control (group 2 versus group 1, p < 0.001) or vehicle control (group 2 versus group 3, p < 0.001) animals. In separate experiments, six baboons were infused with 0.4% hyaluronic acid in phosphate-buffered saline solution in volumes equivalent to 2.5%, 5%, and 10% of the measured circulating blood volume. The 2.5% and 5% infusions had no effect on the parameters measured; infusion of the 10% volume produced transient hemodynamic, coagulation, and gas exchange abnormalities. Hyaluronic acid solutions are efficacious in the prevention of pericardial adhesions in this model, and they appear safe in doses five times the amount needed to prevent adhesions. Further studies investigating the mechanism by which these solutions prevent adhesions, their optimal dose and method of application, and documentation of their safe use in humans are warranted. (J THORAC CARDIOVASC SURG 1994;107:1481-8)
This article has been cited by other articles:
![]() |
I. Yoshioka, Y. Saiki, K. Sakuma, A. Iguchi, T. Moriya, Y. Ikada, and K. Tabayashi Bioabsorbable Gelatin Sheets Latticed With Polyglycolic Acid Can Eliminate Pericardial Adhesion Ann. Thorac. Surg., September 1, 2007; 84(3): 864 - 870. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tsukihara, S. Takamoto, K. Kitahori, K. Matsuda, A. Murakami, R. J. Novick, and Y. Suematsu Prevention of Postoperative Pericardial Adhesions With a Novel Regenerative Collagen Sheet Ann. Thorac. Surg., February 1, 2006; 81(2): 650 - 657. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Walther, A. Rastan, I. Dahnert, V. Falk, S. Jacobs, F. W. Mohr, and M. Kostelka A novel adhesion barrier facilitates reoperations in complex congenital cardiac surgery J. Thorac. Cardiovasc. Surg., February 1, 2005; 129(2): 359 - 363. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Saha, W. McEwan, F. A Frizelle, and H. Singh Limiting Pericardial Adhesions after Coronary Artery Bypass: Experimental Study Asian Cardiovasc Thorac Ann, March 1, 2004; 12(1): 61 - 64. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. van der Linden, O. Duvernoy, L. Hadjinikolaou, and L. Bengtsson Does hyaluronate prevent postoperative retro-sternal adhesions in coronary surgery? - Preliminary results Eur. J. Cardiothorac. Surg., June 1, 2001; 19(6): 949 - 950. [Full Text] [PDF] |
||||
![]() |
S. Verheye, C. P. Markou, M. Y. Salame, B. Wan, S. B. King III, K. A. Robinson, N. A. F. Chronos, and S. R. Hanson Reduced Thrombus Formation by Hyaluronic Acid Coating of Endovascular Devices Arterioscler. Thromb. Vasc. Biol., April 1, 2000; 20(4): 1168 - 1172. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Okuyama, C. Y. Wang, E. A. Rose, K. E. Rodgers, E. Pines, G. S. diZerega, and M. C. Oz Reduction of retrosternal and pericardial adhesions with rapidly resorbable polymer films Ann. Thorac. Surg., September 1, 1999; 68(3): 913 - 918. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Rao, M. Komeda, R. D. Weisel, G. Cohen, M. A. Borger, and T. E. David Should the pericardium be closed routinely after heart operations? Ann. Thorac. Surg., February 1, 1999; 67(2): 484 - 488. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hurle, M. de la Vega, J. J. Feijoo, V. G. Ray, C. Abad, G. Ponce, and J. L. Perez-Arellano Effect of Physical Protection on the Mesothelial Integrity of the Pericardium Ann. Thorac. Surg., April 1, 1997; 63(4): 1091 - 1094. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |